ASLAN Pharmaceuticals Ltd (ASLN)
0.4201
-0.03
(-6.04%)
USD |
NASDAQ |
May 06, 16:00
0.4114
-0.01
(-2.07%)
After-Hours: 20:00
ASLAN Pharmaceuticals Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | 3.770M |
| September 30, 2018 | 0.8471M |
| June 30, 2018 | 36.28M |
| March 31, 2018 | |
| December 31, 2017 | 0.5247M |
| September 30, 2017 | -0.0299M |
| Date | Value |
|---|---|
| June 30, 2017 | 32.79M |
| March 31, 2017 | |
| December 31, 2016 | -1.479M |
| September 30, 2016 | 14.16M |
| June 30, 2016 | 8.876M |
| March 31, 2016 | 9.429M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 64.15M |
| Concord Medical Services Holdings Ltd | -- |
| WAVE Life Sciences Ltd | 93.96M |
| Zai Lab Ltd | 0.393M |
| CytoMed Therapeutics Ltd | -- |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | -905.6% |